3 completed. 3 Phase 3, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 3 | Completed 3 |
| Phase 2 | 1 | Completed 1 |
Follow Zavegepant: new trials by email Literature Review of Zavegepant trials Research Report on Zavegepant
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study to Learn About Zavegepant as the Acute Treatment of Migraine in Asian Adults Zavegepant, Placebo - Migraine | Phase 3 | Completed | Pfizer | 1414 | 2023-11-29 | 2026-05-22 |
| Randomized Trial in Adult Participants With Acute Migraines Zavegepant, Placebo - Migraine | Phase 3 | Completed | Pfizer | 1978 | 2020-10-27 | 2023-04-24 |
| Acute Treatment Trial in Adult Subjects With Migraines Zavegepant, Zavegepant matching placebo, Intranasal Aptar Pharma Unit Dose System - Migraine | Phase 2 / Phase 3 | Completed | Pfizer | 2154 | 2019-03-25 | 2023-09-25 |
Migraine Disorders (3) · Hyperacusis (2) · Nausea (2) · Photophobia (2)
Pfizer (3)
United States (2) · China (1) · South Korea (1) · Taiwan (1)